The board’s decision means patients in Texas will have to be examined in-person by a physician before they can be written a prescription.
The ruling came after roughly four years of feuding with Dallas-based telemedicine firm Teladoc. The decision’s effective date was deferred until June 3, however, to allow the state legislature the chance to consider and weigh in on the matter.
Teladoc released a statement following the board’s ruling, saying, “As Texas’ population booms, healthcare expenses climb and the shortage of primary care physicians grows, telehealth is a solution for patients dealing with common, nonemergency issues…This rule change only serves to intensify these problems without providing any benefit to Texans.”
According to board president, Michael Arambula, MD, PharmD, the decision balances both convenience and safety.
“Texas patients deserve accountability and integrity in the doctor-patient relationship, and the rules adopted today ensure that,” Dr. Arambula told The Dallas Morning News. “Patient safety can never take a backseat to convenience.”
More articles on telemedicine:
How open are patients to telemedicine? Opinions split down the middle, finds Mayo survey
Patient attitudes toward telemedicine: 3 key findings
Children’s Hospital Los Angeles, Mongolian hospital to expand partnership on telemedicine
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
